Frequently asked questions
The pandemic has positively impacted the global antibody cocktails market due to the increasing research and development activities conducted by the key players to develop antibody cocktails and lower the risk of hospitalization in the case of severely COVID-19-infected patients. This is because the pandemic has increased the number of people infected with COVID-19.
North America accounted for the most heightened share in the global antibody cocktail market.
Rising number of COVID-19 cases and increasing prevalence of various cardiovascular disorders will contribute to the growth of the global antibody cocktail market.
The monovalent antibody segment had a major share in the global market in 2022.
The COVID-19 segment had a major share in the global market.